Vistagen Therapeutics Statistics
Total Valuation
VTGN has a market cap or net worth of $84.57 million. The enterprise value is -$2.28 million.
Important Dates
The last earnings date was Thursday, February 13, 2025, after market close.
| Earnings Date | Feb 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
VTGN has 28.86 million shares outstanding. The number of shares has increased by 126.55% in one year.
| Current Share Class | 28.86M |
| Shares Outstanding | 28.86M |
| Shares Change (YoY) | +126.55% |
| Shares Change (QoQ) | +0.26% |
| Owned by Insiders (%) | 0.26% |
| Owned by Institutions (%) | 27.25% |
| Float | 20.22M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 128.53 |
| Forward PS | 115.95 |
| PB Ratio | 1.02 |
| P/TBV Ratio | 1.04 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.35, with a Debt / Equity ratio of 0.02.
| Current Ratio | 9.35 |
| Quick Ratio | 9.20 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -46.28% and return on invested capital (ROIC) is -31.70%.
| Return on Equity (ROE) | -46.28% |
| Return on Assets (ROA) | -29.57% |
| Return on Invested Capital (ROIC) | -31.70% |
| Return on Capital Employed (ROCE) | -63.90% |
| Revenue Per Employee | $17,450 |
| Profits Per Employee | -$1.18M |
| Employee Count | 40 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, VTGN has paid $8,000 in taxes.
| Income Tax | 8,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.40% in the last 52 weeks. The beta is 0.77, so VTGN's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | -41.40% |
| 50-Day Moving Average | 2.81 |
| 200-Day Moving Average | 3.24 |
| Relative Strength Index (RSI) | 53.68 |
| Average Volume (20 Days) | 192,737 |
Short Selling Information
The latest short interest is 744,387, so 2.58% of the outstanding shares have been sold short.
| Short Interest | 744,387 |
| Short Previous Month | 658,063 |
| Short % of Shares Out | 2.58% |
| Short % of Float | 3.68% |
| Short Ratio (days to cover) | 3.34 |
Income Statement
In the last 12 months, VTGN had revenue of $698,000 and -$47.30 million in losses. Loss per share was -$1.55.
| Revenue | 698,000 |
| Gross Profit | 698,000 |
| Operating Income | -52.84M |
| Pretax Income | -29.36M |
| Net Income | -47.30M |
| EBITDA | -52.69M |
| EBIT | -52.84M |
| Loss Per Share | -$1.55 |
Full Income StatementBalance Sheet
The company has $88.56 million in cash and $1.71 million in debt, giving a net cash position of $86.85 million or $3.01 per share.
| Cash & Cash Equivalents | 88.56M |
| Total Debt | 1.71M |
| Net Cash | 86.85M |
| Net Cash Per Share | $3.01 |
| Equity (Book Value) | 81.12M |
| Book Value Per Share | 2.86 |
| Working Capital | 80.32M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$39.02 million and capital expenditures -$132,000, giving a free cash flow of -$39.15 million.
| Operating Cash Flow | -39.02M |
| Capital Expenditures | -132,000 |
| Free Cash Flow | -39.15M |
| FCF Per Share | -$1.36 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -7,569.77% |
| Pretax Margin | -6,775.93% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |